BriefingIndustry newsIndustry briefingNEWSEmergent acquires global rights for smallpox antiviral from ChimerixEmergent BioSolutions has acquired exclusive global rights for oral smallpox antiviral, Tembexa (brincidofovir), from ChimerixnewsMyovant rejects Sumitovant and Sumitomo’s $2.5bn acquisition offerMyovant Sciences has rejected an acquisition offer worth $2.5bn from Sumitovant Biopharma and its wholly-owned subsidiary Sumitomo PharmaBriefingFDA grants approval for Amylyx’s Relyvrio to treat ALSThe US FDA has granted approval for Amylyx Pharmaceuticals’ Relyvrio to treat adult patients with amyotrophic lateral sclerosis (ALS)Industry newsIndustry briefing02/23/2024 23:28:26
Briefing
FDA grants approval for Amylyx’s Relyvrio to treat ALS
The US FDA has granted approval for Amylyx Pharmaceuticals’ Relyvrio to treat adult patients with amyotrophic lateral sclerosis (ALS)